# Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

> **NCT04110418** · PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 36 (estimated)

## Conditions studied

- Neonatal Sepsis
- Refractory Shock

## Interventions

- **DRUG:** Methylene Blue

## Key facts

- **NCT ID:** NCT04110418
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-19
- **Primary completion:** 2020-02-19
- **Final completion:** 2020-02-19
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2019-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110418, "Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04110418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*